STOCK TITAN
  1. Home
  2. News
  3. USNA

Usana Health Sciences Inc - USNA STOCK NEWS

Welcome to our dedicated news page for Usana Health Sciences (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Usana Health Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Usana Health Sciences's position in the market.

News
USANA Schedules First Quarter 2024 Earnings Release and Conference Call
Rhea-AI Summary
USANA Health Sciences, Inc. (USNA) will release its first quarter 2024 results on April 30, 2024, followed by a conference call on May 1, 2024. The Management Commentary will be available on the Investor Relations website. Analysts and investors can access the call online.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
earnings
-
News
USANA Cements Itself as a Premier Cellular Nutrition Company in South Korea
Rhea-AI Summary
USANA Health Sciences wins two awards at the 2024 Korea Medical Healthcare Awards, marking their consistent success in the multivitamin and weight management categories. The event recognizes companies promoting national health and industry development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
none
-
News
Kevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024
Rhea-AI Summary
USANA Health Sciences (NYSE: USNA) emphasizes the importance of a growth mindset in the business world, highlighting the benefits of continuous learning and adaptability. Executive chairman Kevin Guest and psychologist Carol Dweck stress the value of challenges as learning opportunities. Business leaders are encouraged to embrace risk-taking, creativity, and feedback to foster innovation and resilience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
News
Kevin Guest Says Leap Forward on Leap Day
Rhea-AI Summary
USANA Health Sciences executive chairman Kevin Guest provides seven strategies to make the most of Leap Year Day, emphasizing self-care, goal-setting, skill-building, and community service. The company focuses on effective communication for business success, with all proceeds from Guest's book going to feed hungry children.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
News
USANA Sustainability and DEI Executive Director Awarded in Utah
Rhea-AI Summary
USANA Health Sciences, Inc. congratulates Donald Cherry on being named a 40 Under 40 award winner by Utah Business magazine for his role as executive director of corporate sustainability and DEI.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
none
-
News
USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2023 Results
Rhea-AI Summary
USANA Health Sciences, Inc. (NYSE: USNA) announced its fiscal fourth quarter and fiscal year 2023 financial results. Fourth quarter net sales were $221 million, a 3% decrease from Q4 2022, with a 4% sequential increase. Diluted EPS was $0.87, a 32% increase from Q4 2022 and a 47% sequential increase. Fiscal year 2023 net sales were $921 million, an 8% decrease from fiscal year 2022. Diluted EPS for fiscal year 2023 was $3.30, an 8% decrease from fiscal year 2022. The company provided initial fiscal year 2024 net sales and diluted EPS guidance of $850 million to $920 million and $2.40 to $3.00, respectively. USANA President and CEO, Jim Brown, highlighted the positive fourth quarter operating results, attributing the sales growth to a global incentive offering, particularly effective in the Greater China region. Despite 2023 being a challenging year, the company made progress on strategic initiatives, including commencing operations in India, USANA's 25th global market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
earnings
News
Kevin Guest Calls on All to Connect during February Month of Friendship
Rhea-AI Summary
USANA Health Sciences executive chairman Kevin Guest emphasizes the importance of in-person connections during International Friendship Month. The PR highlights the benefits of personal relationships and the impact of digital communication on personal connections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.44%
Tags
none
-
News
USANA Manufacturing Facility Receives Coveted GFSI Certification from SQF
Rhea-AI Summary
USANA recently earned a Global Food Safety Initiative (GFSI) certification for its foods manufacturing facility through the Safe Quality Foods (SQF) program. The certification pertains to USANA's enrobed snack bars and drink mix powders. The company's new 43,000-square-foot manufacturing plant in Salt Lake City, Utah, is state-of-the-art and handles various production processes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.35%
Tags
none
-
News
USANA to Continue Investing in Local Community after Decades-Long Amphitheatre Sponsorship Ends
Rhea-AI Summary
USANA Health Sciences, Inc. announces the end of its 20-year sponsorship of the USANA Amphitheatre, allowing the company to redirect its support to other community-building projects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
none
News
USANA Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
Rhea-AI Summary
USANA Health Sciences, Inc. (USNA) will release its fourth quarter and fiscal year 2023 results on February 6, 2024, followed by a conference call on February 7, 2024, to discuss the announcement with analysts and institutional investors. The Management Commentary document will be available on the Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
earnings
Stock USNA logo
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

#2528 Ranked by Market Cap
#2990 Ranked by Stock Gains
N/A Ranked by Dividends

USNA Stock Data

846.00M
17.96M
41.29%
55.91%
1.29%
Medicinal and Botanical Manufacturing
Manufacturing
Link
US
Salt Lake City

About USNA

usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su